Opzelura (Ruxolitinib)

Opzelura Information:

Buy Opzelura

Opzelura (Ruxolitinib) is a prescription medicine used on the skin (topical) for short-term and non-continuous treatment of mild to moderate eczema (atopic dermatitis) in non-immunocompromised people 12 and older whose disease is not well controlled with topical prescription therapies or when those therapies are not recommended. Eczema is an allergic-type condition that causes red, irritated, and itchy skin. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. This drug works by weakening the skin's defense (immune) system, thereby decreasing the allergic reaction and relieving the eczema. The use of Opzelura along with therapeutic biologics for atopic dermatitis, other JAK inhibitors, or strong immunosuppressants such as azathioprine or cyclosporine is not recommended. It is not known if Opzelura is safe or effective in children less than 12 years of age.

Opzelura from Canada

Canada Drugs Online will be offering you the brand Opzelura from Canada (currently unavailable). Please call us toll free at 1-877-900-3784 for details.

CanadaDrugsOnline.com also carries other skin medications such as Elidel and Topicort.

Opzelura Side Effects:

Common side effects of Opzelura may include pain or swelling in your nose or throat (nasopharyngitis); diarrhea; bronchitis; ear infection; increase in a type of white blood cell (eosinophil) counts; hives; inflamed hair pores (folliculitis); swelling of the tonsils (tonsillitis); runny nose (rhinorrhea).

Contact your doctor immediately if you notice more serious side effects such as:
• Increase in cholesterol. Tell your healthcare provider if you have high levels of fat in your blood (high cholesterol or triglycerides);
• Low blood cell counts;
• Lowering of immune system ability to fight infections;

This is not a complete list of side effects. If you notice any other side effects not listed here, please contact your doctor or pharmacist.

Opzelura Directions:

Opzelura is for use on the skin only. Do not use Opzelura in your eyes, mouth, or vagina. Use this medicine exactly as your healthcare provider tells you. Do not use more than one 60-gram tube each week. Ask your healthcare provider if you have questions about applying Opzelura. Wash your hands after applying Opzelura, unless hands are being treated. If someone else applies Opzelura, they should wash their hands after applying Opzelura.

Opzelura Precautions:

Before using ruxolitinib, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. Before using Opzelura, tell your healthcare provider about all of your medical conditions, including if you have an infection; are being treated for an infection; have or had tuberculosis (TB), or have been in close contact with someone who has TB; have had shingles (herpes zoster); have or had hepatitis B or C; have had skin cancer in the past; are a current or past smoker; have or have had low white or red blood cell counts; have high levels of fat in your blood (high cholesterol or triglycerides); are pregnant or plan to become pregnant; are breastfeeding or plan to breastfeed. It is not known if Opzelura passes into your breast milk. Do not breastfeed during treatment with Opzelura and for about 4 weeks after the last dose. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.